Risedronate tablets, including delayed-release (long-acting tablets), serve the purpose of preventing and managing osteoporosis, which is characterized by the weakening and thinning of bones, making them susceptible to fractures. These tablets are primarily used by postmenopausal women, men with osteoporosis, individuals taking glucocorticoids (a type of corticosteroid medication that can lead to osteoporosis), and those with Paget’s disease of bone.